CASP3 and chondrosarcoma: Moreover, pretreatment of cells with histone deacetylase inhibitor MS-27537 could also significantly reverse the increased cleavage of caspase-3 protein (Fig. 5A) and caspase-3 activity (Fig. 5B) in resveratrol-treated chondrosarcoma cells.